Vitamin E, Selenium and Soy in Combination Does Not Prevent Prostate Cancer

The combination therapy of vitamin E, selenium and soy does not prevent the progression from high-grade prostatic intraepithelial neoplasia (HGPIN) to prostate cancer, according to the new research presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA). The study confirms the findings of the Selenium and Vitamin E Cancer Prevention Trial (SELECT) and expands knowledge of the affect soy has on prostate cancer.

Canadian researchers divided 303 men, with an average age of 62, into two randomized groups. All participants had HGPIN, a precursor to invasive prostate cancer, as confirmed by a central pathology review in at least one of two biopsies within 18 months prior to randomization. The combination treatment was administered daily for three years with follow-up prostate biopsies at six, 12, 24 and 36 months. Supplementation was discontinued if a man developed invasive disease. Study results show that 26.4 percent of patients developed invasive prostate cancer. Baseline, age, weight and testosterone levels did not predict the development of cancer.

“Unfortunately, as this study shows, we have yet to find a dietary supplement that will reliably prevent prostate cancer. The results of this study support the findings of the SELECT trial which also demonstrated no benefit using Vitamin E and selenium,” said Christopher Amling, MD, an AUA spokesman.

“These studies highlight the importance of conducting randomized trials of these agents since many of these supplements are promoted falsely to the general public as having beneficial effects on cancer prevention and progression.”

NOTE TO REPORTERS: Experts are available to discuss this study outside normal briefing times.

Fleshner, N; Kapusta, L; Hersey, K; Farley, A; Lawrentschuk, N; Donnelly, B; Chin, J; Gleave, M; Klotz, L; Trypkov, C; Tu, D; Parulekar, W. Randomized trial of combination vitamin E, selenium and soy protein among men with high grade prostatic intraepithelial neoplasia (HGPIN). J Urol, suppl. 2009: 181, 4, abstract 736.

About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is the pre-eminent professional organization for urologists, with more than 16,000 members throughout the world. An educational nonprofit organization, the AUA pursues its mission of fostering the highest standards of urologic care by carrying out a wide variety of programs for members and their patients.

Source: American Urological Association (AUA)

RELATED STORIES:
Prostate Cancer Patients Sought for Database as Part of Joint Effort   Scientists discover way to block growth of prostate cancer cells   Sometimes No Treatment is the Right Option for Low-Risk Prostate Cancer   Prostate cancer treatment choices vary based on type of specialist consulted   Shorter radiation course stops cancer growth in high-risk prostate cancer patients   Researchers Uncover How Prostate Cancer Cells Defy Death   Pre-surgery sessions boost prostate patients’ mood   Prostate Cancer Treatment Increases Risk of Diabetes and Heart Disease   Radiation therapy technique reduces length of prostate cancer treatment   Dramatic Outcomes in Prostate Cancer Study   Rotating-shift work tied to prostate cancer risk   Long-term hormone therapy best for prostate cancer   Few Side Effects from Radiation Treatment Given After Prostate Cancer Surgery   Prostate cancer patients see high survival rates with seed implants   Trimodal approach to prostate cancer promising   Exercise Reduces Death Rate in Prostate Cancer Patients   Accurate Prostate Cancer Diagnosis Depends on Biopsy Location   U.S. Trial Shows No Early Mortality Benefit from Annual Prostate Cancer Screening   Freezing prostate cancer does a man’s body good   Delaying therapy OK for low-risk prostate cancer   Alternative therapy common in prostate cancer   Turmeric holds real potential for the treatment and prevention of prostate cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]